Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative compounded medications in...
Nicox SA engages in the research, development and future commercialization of drug candidates. The company is applying its proprietary nitric...
NascaCell Technologies AG
Munich , BV 81377
SIC Code: 2834